Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
1.913
+0.042 (2.27%)
At close: Aug 1, 2025, 4:00 PM
1.881
-0.031 (-1.64%)
After-hours: Aug 1, 2025, 4:13 PM EDT
Minerva Neurosciences Employees
Minerva Neurosciences had 8 employees as of December 31, 2024. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
$781,837
Market Cap
13.37M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8 | -1 | -11.11% |
Dec 31, 2023 | 9 | 0 | - |
Dec 31, 2022 | 9 | 0 | - |
Dec 31, 2021 | 9 | -2 | -18.18% |
Dec 31, 2020 | 11 | -2 | -15.38% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NERV News
- 2 months ago - Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 5 months ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 9 months ago - Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - US FDA declines to approve Minerva Neurosciences' schizophrenia drug - Reuters
- 1 year ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates - GlobeNewsWire
- 2 years ago - Minerva Neurosciences: There's Probably Time For One More Rally - Seeking Alpha